The global cosmetic surgery market size reached USD 88.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 204.9 Billion by 2033, exhibiting a growth rate (CAGR) of 9.23% during 2025-2033. The increasing prevalence of skin-related diseases, rising awareness among individuals about new procedures, and the advent of smart implants represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 88.9 Billion |
Market Forecast in 2033 | USD 204.9 Billion |
Market Growth Rate (2025-2033) | 9.23% |
Cosmetic surgery, also known as aesthetic surgery, is performed to enhance or change the appearance of a person. It comprises various surgical and non-invasive procedures that aid in improving the physical appearance, enhancing self esteem and confidence, correcting physical deformities or asymmetries, and improving the look of scars or other skin imperfections among individuals. At present, the expanding cosmetic and medical tourism, rising investments in improving healthcare infrastructure, and the development of high-quality healthcare services in several countries are catalyzing the demand for these surgeries across the globe.
The increasing focus of individuals on improving their physical appearance, along with the rising influence of social media platforms, currently represents one of the major factors driving the demand for cosmetic surgeries around the world. Moreover, the surging prevalence of skin-related diseases, such as acne vulgaris, on account of sedentary lifestyles, unhealthy dietary patterns, hormonal imbalance and insomnia is favoring the market growth. In addition, there is an increase in the prevalence of obesity and other diseases that lead to excess fat accumulation in the body. This, in confluence with the growing global aging population, which is prone to develop sagging and loose skin, is influencing the market positively. Apart from this, governing agencies of numerous countries are undertaking measures to improve the safety of cosmetic procedures and generate awareness among individuals about new and advanced cosmetic procedures. Furthermore, there is an increase in the demand for minimally invasive (MI) surgical procedures around the world. Besides this, there is a rise in the integration of 3D printing, augmented reality (AR), virtual reality (VR), and artificial intelligence (AI) in cosmetic surgeries to create precise surgical guides, prosthetics, and implants and improve the accuracy and outcomes of procedures. These advanced technologies also help analyze data and images to optimize surgical planning, improve patient outcomes, and reduce human error. This, coupled with the advent of smart implants that help monitor and adapt to changes in the body, communicate with other devices like smartphones and provide real time data on the condition of the patient, is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the global cosmetic surgery market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on procedure, gender, age group, and end user.
Procedure Insights:
The report has provided a detailed breakup and analysis of the cosmetic surgery market based on the procedure. This includes surgical procedures (breast augmentation, liposuction, eyelid surgery, abdominoplasty, rhinoplasty, and others) and non-surgical procedures (botulinum toxin, hyaluronic acid, hair removal, nonsurgical fat reduction, photo rejuvenation, and other). According to the report, surgical procedures represented the largest segment.
Gender Insights:
A detailed breakup and analysis of the cosmetic surgery market based on the gender has also been provided in the report. This includes female and male. According to the report, females represented the largest segment.
Age Group Insights:
The report has provided a detailed breakup and analysis of the cosmetic surgery market based on the age group. This includes 13 To 29, 30 To 54, and 55 and above. According to the report, 30 to 54 represented the largest segment.
End User Insights:
A detailed breakup and analysis of the cosmetic surgery market based on the end user has also been provided in the report. This includes ambulatory surgical facility, hospitals and clinics, and others. According to the report, hospitals and clinics represented the largest segment.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cosmetic surgery. Some of the factors driving the North America cosmetic surgery market included the growing demand for minimally invasive procedures, increasing adoption of cosmetic surgeries among older adultes, and the availability of advanced technologies.
The report has also provided a comprehensive analysis of the competitive landscape in the global cosmetic surgery market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered AbbVie Inc., Alma Laser [Shanghai Fosun Pharmaceutical (Group) Co. Ltd], Cutera Inc., Cynosure LLC, Genesis Biosystems Inc., Long Island Plastic Surgical Group PC, Lumenis Inc (Boston Scientific Corporation), Sientra Inc., Sinclair Pharmaceuticals Limited, Solta Medical (Bausch Health Companies Inc.), Syneron Candela, Teoxane Laboratories, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Procedures Covered |
|
Genders Covered | Female, Male |
Age Groups Covered | 13 To 29, 30 To 54, 55 and Above |
End Users Covered | Ambulatory Surgical Facility, Hospitals and Clinics, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | AbbVie Inc., Alma Laser [Shanghai Fosun Pharmaceutical (Group) Co. Ltd], Cutera Inc., Cynosure LLC, Genesis Biosystems Inc., Long Island Plastic Surgical Group PC, Lumenis Inc (Boston Scientific Corporation), Sientra Inc., Sinclair Pharmaceuticals Limited, Solta Medical (Bausch Health Companies Inc.), Syneron Candela, Teoxane Laboratories, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global cosmetic surgery market was valued at USD 88.9 Billion in 2024.
We expect the global cosmetic surgery market to exhibit a CAGR of 9.23% during 2025-2033.
The rising focus of individuals on improving their physical appearance, along with the introduction of smart implants that help monitor and adapt to changes in the body, communicate with other devices, and provide real time data on the condition of the patient, is primarily driving the global cosmetic surgery market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cosmetic surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.
Based on the procedure, the global cosmetic surgery market has been divided into surgical procedures and non-surgical procedures, where surgical procedures currently exhibit a clear dominance in the market.
Based on the gender, the global cosmetic surgery market can be categorized into female and male. Currently, female accounts for the majority of the global market share.
Based on the age group, the global cosmetic surgery market has been segregated into 13 to 29, 30 to 54, and 55 and above. Among these, 30 to 54 currently holds the largest market share.
Based on the end user, the global cosmetic surgery market can be bifurcated into ambulatory surgical facility, hospitals and clinics, and others. Currently, hospitals and clinics exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global cosmetic surgery market include AbbVie Inc., Alma Laser [Shanghai Fosun Pharmaceutical (Group) Co. Ltd], Cutera Inc., Cynosure LLC, Genesis Biosystems Inc., Long Island Plastic Surgical Group PC, Lumenis Inc (Boston Scientific Corporation), Sientra Inc., Sinclair Pharmaceuticals Limited, Solta Medical (Bausch Health Companies Inc.), Syneron Candela, Teoxane Laboratories, etc.